Shortages and drug-resistant germs have renewed attention on a $6 billion proposal in Congress that would reconfigure the way antimicrobial drugs are developed and sold.
This post first appeared in The New York Times – Business. Read the original article.Can a Federally Funded ‘Netflix Model’ Fix the Broken Market for Antibiotics?
The New York Times – Business:
Written by
in
